MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Country/Region

Topic

May 24, 2018

Doctors Without Borders/Médecins Sans Frontières (MSF) made the following statement after the adoption of a resolution on “Addressing the burden of snakebite envenoming” during the 71st World Health Assembly today.

May 22, 2018

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes the launch of the Global Research & Development (R&D) collaboration hub on antimicrobial resistance (AMR) announced at the World Health Assembly today.

May 11, 2018

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) made the following statement today in response to President Trump’s speech on drug pricing.

April 27, 2018

The Office of the United States Trade Representative (USTR) released its annual “Special 301 Report” today, which reviews countries based on their intellectual property (IP) rights protection and enforcement. Countries that are deemed by the U.S. to not protect IP strongly enough are placed on this watch list.

March 23, 2018

Khumbulani, 16, has multidrug-resistant tuberculosis (MDR-TB). In 2017, he lost his hearing. In early 2018, his eyesight faded. The side effects were not from the disease, but from Khumbulani's treatment. Better drugs for resistant strains of TB exist, but too few people have access to them. It's time to #StepUpForTB

March 03, 2018

This article was originally published in The Hill

The White House Council of Economic Advisers recently announced a strategy to curb high drug prices: force "free riding" countries abroad to pay more and watch the prices go down in America.

February 12, 2018

An international conference on the reconstruction of Iraq is underway in Kuwait this week. Carla Brooijmans, Doctors Without Borders/Médecins Sans Frontières (MSF) head of mission for Iraq, gave the following statement after a meeting in Kuwait today of aid organizations responding to humanitarian needs in Iraq:

February 06, 2018

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) has filed a legal petition to the Supreme Court of South Korea requesting that the court review Pfizer’s patent to for its pneumococcal conjugate vaccine (PCV).

January 24, 2018

Snakebite venom permanently disables hundreds of thousands of people and kills more than 100,000 each year across the globe—more than any other neglected tropical disease designated by the World Health Organization (WHO)—even though highly effective treatments exist.

December 18, 2017

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) has filed a patent challenge in China to block Gilead’s patent application for the combination of two key oral hepatitis C medicines, sofosbuvir and velpatasvir.

Pages

May 24, 2018

Doctors Without Borders/Médecins Sans Frontières (MSF) made the following statement after the adoption of a resolution on “Addressing the burden of snakebite envenoming” during the 71st World Health Assembly today.

May 22, 2018

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes the launch of the Global Research & Development (R&D) collaboration hub on antimicrobial resistance (AMR) announced at the World Health Assembly today.

May 11, 2018

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) made the following statement today in response to President Trump’s speech on drug pricing.

April 27, 2018

The Office of the United States Trade Representative (USTR) released its annual “Special 301 Report” today, which reviews countries based on their intellectual property (IP) rights protection and enforcement. Countries that are deemed by the U.S. to not protect IP strongly enough are placed on this watch list.

March 23, 2018

Khumbulani, 16, has multidrug-resistant tuberculosis (MDR-TB). In 2017, he lost his hearing. In early 2018, his eyesight faded. The side effects were not from the disease, but from Khumbulani's treatment. Better drugs for resistant strains of TB exist, but too few people have access to them. It's time to #StepUpForTB

March 03, 2018

This article was originally published in The Hill

The White House Council of Economic Advisers recently announced a strategy to curb high drug prices: force "free riding" countries abroad to pay more and watch the prices go down in America.

February 12, 2018

An international conference on the reconstruction of Iraq is underway in Kuwait this week. Carla Brooijmans, Doctors Without Borders/Médecins Sans Frontières (MSF) head of mission for Iraq, gave the following statement after a meeting in Kuwait today of aid organizations responding to humanitarian needs in Iraq:

February 06, 2018

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) has filed a legal petition to the Supreme Court of South Korea requesting that the court review Pfizer’s patent to for its pneumococcal conjugate vaccine (PCV).

January 24, 2018

Snakebite venom permanently disables hundreds of thousands of people and kills more than 100,000 each year across the globe—more than any other neglected tropical disease designated by the World Health Organization (WHO)—even though highly effective treatments exist.

December 18, 2017

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) has filed a patent challenge in China to block Gilead’s patent application for the combination of two key oral hepatitis C medicines, sofosbuvir and velpatasvir.

Pages